Estimates Revisions Entrada Therapeutics, Inc.
Stocks
TRDA
US29384C1080
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.560 USD | -0.61% |
|
-12.01% | -36.24% |
| 06-29 | Entrada Therapeutics, Inc.(NasdaqGM:TRDA) dropped from Russell 2000 Defensive Index | CI |
| 06-28 | Entrada Therapeutics, Inc.(NasdaqGM:TRDA) dropped from Russell 2000 Value-Defensive Index | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- TRDA Stock
- Consensus Entrada Therapeutics, Inc.
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
